Cargando…

An Outcome Assessment of a Single Institution’s Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis

There is no FDA-approved treatment for metastatic uveal melanoma (UM) and overall outcomes are generally poor for those who develop liver metastasis. We performed a retrospective single-institution chart review on consecutive series of UM patients with liver metastasis who were treated at Thomas Jef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seedor, Rino S., Eschelman, David J., Gonsalves, Carin F., Adamo, Robert D., Orloff, Marlana, Amjad, Anjum, Sharpe-Mills, Erin, Chervoneva, Inna, Shields, Carol L., Shields, Jerry A., Mastrangelo, Michael J., Sato, Takami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016993/ https://www.ncbi.nlm.nih.gov/pubmed/31906411 http://dx.doi.org/10.3390/cancers12010117

Ejemplares similares

Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Seedor, Rino S., et al.
Publicado: (2021)

Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
por: Terai, Mizue, et al.
Publicado: (2015)

Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification (Simplified Version) in 1001 cases
por: Shields, Carol L., et al.
Publicado: (2021)

Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2021)

A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma
por: Minor, David R., et al.
Publicado: (2022)

Uveal melanoma: Estimating prognosis
por: Kaliki, Swathi, et al.
Publicado: (2015)

Improved Uveal Melanoma Copy Number Subtypes Including an Ultra–High-Risk Group
por: Lalonde, Emilie, et al.
Publicado: (2022)

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
por: Wei, Alexander Z., et al.
Publicado: (2022)

Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2020)

Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma
por: Masoomian, Babak, et al.
Publicado: (2018)

From Lepidoptera to uveal melanoma: Finding my career in ocular oncology
por: Shields, Jerry A
Publicado: (2019)

Conjunctival melanoma with orbital invasion and liver metastasis managed with systemic immune checkpoint inhibitor therapy
por: Chang, Michael, et al.
Publicado: (2019)

Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review
por: Shields, Carol L, et al.
Publicado: (2019)

Using risk factors for detection and prognostication of uveal melanoma
por: Rishi, Pukhraj, et al.
Publicado: (2015)

American joint committee on cancer staging of uveal melanoma
por: Mellen, Phoebe L., et al.
Publicado: (2013)

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma
por: Chua, Vivian, et al.
Publicado: (2019)

Uveal effusion syndrome in 104 eyes: Response to corticosteroids – The 2017 Axel C. Hansen lecture
por: Shields, Carol L, et al.
Publicado: (2017)

Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases
por: Shields, Carol L, et al.
Publicado: (2021)

Intratumoral bacteria in uveal melanoma: A case report
por: Vega Escobar, Katherine, et al.
Publicado: (2023)

Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
por: Orloff, Marlana
Publicado: (2016)

Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma
por: Djulbegovic, Mak B., et al.
Publicado: (2022)

Intrinsic disorder in PRAME and its role in uveal melanoma
por: Antonietti, Michael, et al.
Publicado: (2023)

Correction: Intrinsic disorder in PRAME and its role in uveal melanoma
por: Antonietti, Michael, et al.
Publicado: (2023)

Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma
por: Carvajal, Richard D., et al.
Publicado: (2022)

Conditional Metastasis of Uveal Melanoma in 8091 Patients over Half-Century (51 Years) by Age Group: Assessing the Entire Population and the Extremes of Age
por: Shields, Carol L., et al.
Publicado: (2023)

Uveal Metastasis Based on Patient Sex in 2214 Tumors of 1111 Patients. A Comparison of Female Versus Male Clinical Features and Outcomes
por: Welch, R. Joel, et al.
Publicado: (2019)

Psychometric Results of a New Patient-Reported Outcome Measure for Uveal Melanoma Post-Brachytherapy Treatment: The PROM-UM
por: Weis, Ezekiel, et al.
Publicado: (2023)

PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma
por: Vaquero-Garcia, Jorge, et al.
Publicado: (2017)

A pilot exploration using optical coherence tomography angiography analysis of capillary vascular density and foveal avascular zone for the diagnosis of uveal melanoma
por: Chien, Jason L., et al.
Publicado: (2020)

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis
por: Kageyama, Ken, et al.
Publicado: (2017)

Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma
por: Ewens, K. G., et al.
Publicado: (2018)

Small Choroidal Melanoma with Monosomy 3
por: Ghassemi, Fariba, et al.
Publicado: (2010)

Uveal metastasis in 1111 patients: Interval to metastasis and overall survival based on timing of primary cancer diagnosis
por: Welch, R. Joel, et al.
Publicado: (2019)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Cystoid macular edema as the initial manifestation of choroidal melanoma
por: Garoon, Robert B., et al.
Publicado: (2012)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

Iris melanoma in children: Current approach to management
por: McLaughlin, John P., et al.
Publicado: (2013)

Distinguishing midzonal iris pigment epithelial cyst from adenoma and ciliary body melanoma
por: Mayro, Eileen L., et al.
Publicado: (2018)

Trends in the management of intraocular tumors over 40 years
por: Shields, Jerry A, et al.
Publicado: (2015)

Tumors of the conjunctiva and cornea
por: Shields, Carol L, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b72osr77puvmao5fal4una5k10